331 related articles for article (PubMed ID: 28884797)
1. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature.
Vekic DA; Woods J; Lin P; Cains GD
Int J Dermatol; 2018 Jan; 57(1):10-18. PubMed ID: 28884797
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate.
Genovese G; Caorsi R; Moltrasio C; Marzano AV
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():40-41. PubMed ID: 31535768
[TBL] [Abstract][Full Text] [Related]
3. SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report.
Luzzati M; Simonini G; Filippeschi C; Giani T; Trapani S
Ital J Pediatr; 2020 Nov; 46(1):169. PubMed ID: 33187546
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections.
Crowley EL; O'Toole A; Gooderham MJ
SAGE Open Med Case Rep; 2018; 6():2050313X18778723. PubMed ID: 29922466
[TBL] [Abstract][Full Text] [Related]
5. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
De Souza A; Solomon GE; Strober BE
Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of severe SAPHO syndrome with adalimumab: case report and a review of the literature.
Garcovich S; Amelia R; Magarelli N; Valenza V; Amerio P
Am J Clin Dermatol; 2012 Feb; 13(1):55-9. PubMed ID: 22007948
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms.
Maronese CA; Moltrasio C; Marzano AV
Dermatol Clin; 2024 Apr; 42(2):247-265. PubMed ID: 38423685
[TBL] [Abstract][Full Text] [Related]
8. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
Przepiera-Będzak H; Brzosko M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):305-306. PubMed ID: 28128085
[TBL] [Abstract][Full Text] [Related]
10. Gingival pustules and sterile diffuse sclerosing osteomyelitis as a feature of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
Chou A; Schulman JM; Gross AJ; Jordan RC; Ramos DM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):e116-22. PubMed ID: 26619759
[TBL] [Abstract][Full Text] [Related]
11. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab.
Fattore D; Pistone G; Bongiorno MR
G Ital Dermatol Venereol; 2019 Apr; 154(2):218-220. PubMed ID: 29368847
[No Abstract] [Full Text] [Related]
13. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
Groleau PF; Grossberg AL; Gaspari AA
Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of a childhood synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with subcutaneous methotrexate: A case report.
Akçaboy M; Bakkaloğlu-Ezgü SA; Büyükkaragöz B; Isıyel E; Kandur Y; Hasanoğlu E; Buyan N
Turk J Pediatr; 2017; 59(2):184-188. PubMed ID: 29276872
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
Bruzzese V
J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
[TBL] [Abstract][Full Text] [Related]
16. [Methotrexate to treat SAPHO syndrome with keloidal scars].
Azevedo VF; Dal Pizzol VI; Lopes H; Coelho SP; Czeczko LE
Acta Reumatol Port; 2011; 36(2):167-70. PubMed ID: 21841736
[TBL] [Abstract][Full Text] [Related]
17. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature.
Moll C; Hernández MV; Cañete JD; Gómez-Puerta JA; Soriano A; Collado A; Sanmartí R
Semin Arthritis Rheum; 2008 Apr; 37(5):299-306. PubMed ID: 17976692
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Reddick CL; Singh MN; Chalmers RJ
Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
[TBL] [Abstract][Full Text] [Related]
19. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work.
Zhao Z; Li Y; Li Y; Zhao H; Li H
J Dermatol; 2011 Feb; 38(2):155-9. PubMed ID: 21269311
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of ultrasonography in synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome: A case report.
Asano T; Furuya MY; Fujita Y; Matsuoka N; Sato S; Kobayashi H; Watanabe H; Honda A; Migita K
Medicine (Baltimore); 2018 Oct; 97(41):e12725. PubMed ID: 30313072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
